Venture Capital Funding Survey, Third Quarter 2014
VENTURE CAPITAL FUNDING, THIRD QUARTER 2014 This is a listing of many of the Bay Area firms that received venture capital financing between July 1 and Sept 30, 2014. Most of the data was compiled from a survey conducted by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association in conjunction with the Mercury News. In the case of some investments there may have been other participants in the round who are not credited. Also, the amounts listed may not include all venture funding the company received during the quarter. *Indicates this is a seed or first-round infusion of money from venture capitalists. These companies may have received money previously from other investors and aren't necessarily startups.
BIOTECHNOLOGY / HEALTH Name 3-V Biosciences
City Menlo Park
Stage Early Stage
Afferent Pharmaceuticals San Mateo
Early Stage
$2,700,000 Domain Associates, undisclosed firm
Clinical-stage biopharmaceutical company.
Airxpanders
Palo Alto
Expansion
$5,661,000 GBS Venture Partners, Prolog Ventures, Vivo Ventures
Breast cancer reconstruction.
Aldea Pharmaceuticals
Redwood City
Expansion
$9,263,000 Canaan Partners, Correlation Ventures, RusnanoMedInvest, undisclosed firms
Pharmaceutical company.
Allakos
San Carlos
Early Stage
Armetheon*
Menlo Park
Early Stage
Avinger
Redwood City
Expansion
$34,831,000 Lucas Venture Group
Biomimedica
South San Francisco South San Francisco
Early Stage
$250,000 Emergent Medical Partners $16,000,000 Advanced Technology Ventures, Delphi Ventures, Morgenthaler Ventures, T. Rowe Price Threshold Partnerships, undisclosed firms, Wellington Management
Calithera Biosciences
Early Stage
Amount Investors Description $3,499,000 Kleiner Perkins Caufield & Therapeutics that modulate Byers, New Enterprise pathways for the treatment Associates of oncology.
$15,000,000 Alta Partners, De Novo Ventures, F Hoffmann La Roche AG, RiverVest Venture Partners
Biotechnology company.
$7,000,000 AshHill Pharmaceutical Drugs for cardiovascular Investments, undisclosed diseases. firms
Page 1 of 21
Image-guided therapeutic devices. Medical device company. Therapeutics company.